Rockwell Medical CDO Raymond Pratt resigns effective March 25, 2022

ROCKWELL MEDICAL, INC.

Raymond Pratt, Chief Development Officer, notified resignation on March 14, 2022.
Resignation effective March 25, 2022; no reason disclosed.
No replacement named; CEO Russell Ellison signed the filing.
Departure follows no previously announced succession plan.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Raymond Pratt

Chief Development Officer

RMTI · ROCKWELL MEDICAL, INC.

Effective: 2022-03-25
Filed: March 18, 2022, 7:59 PM ET

On March 14, 2022, Raymond Pratt notified the Company of his decision to resign as the Company’s Chief Development Officer, effective as of March 25, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Raymond Pratt resigned as Chief Development Officer at ROCKWELL MEDICAL, INC..

Action: resigned
Role: Chief Development Officer

Exact text from the filing

On March 14, 2022, Raymond Pratt notified the Company of his decision to resign as the Company’s Chief Development Officer, effective as of March 25, 2022.

View on SEC.gov

ROCKWELL MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001104659-22-035585

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.